HGSI shares soar

Human Genome Sciences (HGSI) was up $33.25 (21 percent) to $188 on the day on news that it had received U.S. Patent No. 6,025,154 covering the CCR5 receptor gene. CCR5, a G-protein coupled receptor, f...